Premature Translational Termination Products Are Rapidly Degraded Substrates for MHC Class I Presentation

• Joshua R. Lacsina,

  Affiliations Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Odessa A. Marks,

  Affiliation Department of Molecular Biomedical Sciences, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, United States of America

  ⨯
• Xiongfei Liu,

  Affiliation Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• David W. Reid,

  Affiliation Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Sujatha Jagannathan,

  Affiliation Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯
• Christopher V. Nicchitta

  * E-mail: christopher.nicchitta@duke.edu

  Affiliations Department of Pathology, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Cell Biology, Duke University School of Medicine, Durham, North Carolina, United States of America, Department of Biochemistry, Duke University School of Medicine, Durham, North Carolina, United States of America

  ⨯